CN114344218B - 一种净痘乳液及其制备方法 - Google Patents
一种净痘乳液及其制备方法 Download PDFInfo
- Publication number
- CN114344218B CN114344218B CN202210090264.5A CN202210090264A CN114344218B CN 114344218 B CN114344218 B CN 114344218B CN 202210090264 A CN202210090264 A CN 202210090264A CN 114344218 B CN114344218 B CN 114344218B
- Authority
- CN
- China
- Prior art keywords
- parts
- extract
- acne
- glycerol
- alcohol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 208000002874 Acne Vulgaris Diseases 0.000 title claims abstract description 76
- 206010000496 acne Diseases 0.000 title claims abstract description 76
- 239000000839 emulsion Substances 0.000 title claims abstract description 56
- 238000002360 preparation method Methods 0.000 title abstract description 15
- 238000004945 emulsification Methods 0.000 title description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 65
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 claims abstract description 46
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims abstract description 44
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 34
- 239000003921 oil Substances 0.000 claims abstract description 34
- 235000019198 oils Nutrition 0.000 claims abstract description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 27
- 239000002994 raw material Substances 0.000 claims abstract description 24
- 229960000735 docosanol Drugs 0.000 claims abstract description 23
- NKJOXAZJBOMXID-UHFFFAOYSA-N 1,1'-Oxybisoctane Chemical compound CCCCCCCCOCCCCCCCC NKJOXAZJBOMXID-UHFFFAOYSA-N 0.000 claims abstract description 22
- OKMWKBLSFKFYGZ-UHFFFAOYSA-N 1-behenoylglycerol Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(O)CO OKMWKBLSFKFYGZ-UHFFFAOYSA-N 0.000 claims abstract description 22
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims abstract description 22
- 241001135917 Vitellaria paradoxa Species 0.000 claims abstract description 22
- 229960000541 cetyl alcohol Drugs 0.000 claims abstract description 22
- 235000019864 coconut oil Nutrition 0.000 claims abstract description 22
- 239000003240 coconut oil Substances 0.000 claims abstract description 22
- 229940057910 shea butter Drugs 0.000 claims abstract description 22
- 235000010493 xanthan gum Nutrition 0.000 claims abstract description 22
- 239000000230 xanthan gum Substances 0.000 claims abstract description 22
- 229920001285 xanthan gum Polymers 0.000 claims abstract description 22
- 229940082509 xanthan gum Drugs 0.000 claims abstract description 22
- GHVNFZFCNZKVNT-UHFFFAOYSA-M decanoate Chemical compound CCCCCCCCCC([O-])=O GHVNFZFCNZKVNT-UHFFFAOYSA-M 0.000 claims abstract description 20
- 239000008367 deionised water Substances 0.000 claims abstract description 20
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 20
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims abstract description 17
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 108010039918 Polylysine Proteins 0.000 claims abstract description 17
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 17
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000000787 lecithin Substances 0.000 claims abstract description 17
- 235000010445 lecithin Nutrition 0.000 claims abstract description 17
- 229940067606 lecithin Drugs 0.000 claims abstract description 17
- 229960005323 phenoxyethanol Drugs 0.000 claims abstract description 17
- 229920000656 polylysine Polymers 0.000 claims abstract description 17
- 235000020238 sunflower seed Nutrition 0.000 claims abstract description 17
- 229940046009 vitamin E Drugs 0.000 claims abstract description 17
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 17
- 239000011709 vitamin E Substances 0.000 claims abstract description 17
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 claims abstract description 16
- 244000062730 Melissa officinalis Species 0.000 claims abstract description 11
- 235000010654 Melissa officinalis Nutrition 0.000 claims abstract description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 14
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 claims description 14
- 238000003756 stirring Methods 0.000 claims description 14
- 241000244365 Ligusticum sinense Species 0.000 claims description 11
- 238000010438 heat treatment Methods 0.000 claims description 11
- 238000011282 treatment Methods 0.000 claims description 10
- 241001164374 Calyx Species 0.000 claims description 8
- 241001646826 Isodon rubescens Species 0.000 claims description 8
- 240000005790 Oroxylum indicum Species 0.000 claims description 8
- 235000012920 Oroxylum indicum Nutrition 0.000 claims description 8
- 244000064622 Physalis edulis Species 0.000 claims description 8
- 238000001816 cooling Methods 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 claims description 7
- 239000005770 Eugenol Substances 0.000 claims description 7
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 claims description 7
- 229960002217 eugenol Drugs 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 229960003512 nicotinic acid Drugs 0.000 claims description 7
- 235000001968 nicotinic acid Nutrition 0.000 claims description 7
- 239000011664 nicotinic acid Substances 0.000 claims description 7
- 229940049654 glyceryl behenate Drugs 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 239000011344 liquid material Substances 0.000 claims description 6
- 238000007599 discharging Methods 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- 235000005979 Citrus limon Nutrition 0.000 claims description 4
- 244000131522 Citrus pyriformis Species 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 239000011347 resin Substances 0.000 claims description 3
- 229920005989 resin Polymers 0.000 claims description 3
- 238000001291 vacuum drying Methods 0.000 claims description 3
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 claims description 2
- 241000588923 Citrobacter Species 0.000 claims description 2
- 239000003463 adsorbent Substances 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 229960002446 octanoic acid Drugs 0.000 claims description 2
- 235000013305 food Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 24
- 239000006210 lotion Substances 0.000 abstract description 24
- 230000007794 irritation Effects 0.000 abstract description 5
- 230000007774 longterm Effects 0.000 abstract description 5
- 206010020751 Hypersensitivity Diseases 0.000 abstract description 2
- 208000026935 allergic disease Diseases 0.000 abstract description 2
- 230000007815 allergy Effects 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 28
- 241000283973 Oryctolagus cuniculus Species 0.000 description 18
- 230000000052 comparative effect Effects 0.000 description 18
- 235000011187 glycerol Nutrition 0.000 description 17
- 210000005069 ears Anatomy 0.000 description 12
- 230000003110 anti-inflammatory effect Effects 0.000 description 7
- 206010015150 Erythema Diseases 0.000 description 6
- 239000007858 starting material Substances 0.000 description 6
- 240000007711 Peperomia pellucida Species 0.000 description 5
- 201000004624 Dermatitis Diseases 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 241000972673 Phellodendron amurense Species 0.000 description 4
- 208000003251 Pruritus Diseases 0.000 description 4
- 230000000172 allergic effect Effects 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 208000010668 atopic eczema Diseases 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000035755 proliferation Effects 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 239000002344 surface layer Substances 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 230000037303 wrinkles Effects 0.000 description 3
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- 208000032544 Cicatrix Diseases 0.000 description 2
- 241000112528 Ligusticum striatum Species 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000003255 anti-acne Effects 0.000 description 2
- 230000000922 anti-bactericidal effect Effects 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 210000000613 ear canal Anatomy 0.000 description 2
- 210000003780 hair follicle Anatomy 0.000 description 2
- 238000000265 homogenisation Methods 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 230000037387 scars Effects 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- RBNPOMFGQQGHHO-UHFFFAOYSA-N -2,3-Dihydroxypropanoic acid Natural products OCC(O)C(O)=O RBNPOMFGQQGHHO-UHFFFAOYSA-N 0.000 description 1
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 1
- 241000186427 Cutibacterium acnes Species 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- RBNPOMFGQQGHHO-UWTATZPHSA-N D-glyceric acid Chemical compound OC[C@@H](O)C(O)=O RBNPOMFGQQGHHO-UWTATZPHSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- SHGAZHPCJJPHSC-NUEINMDLSA-N Isotretinoin Chemical compound OC(=O)C=C(C)/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-NUEINMDLSA-N 0.000 description 1
- 241000972672 Phellodendron Species 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 239000004902 Softening Agent Substances 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 230000002280 anti-androgenic effect Effects 0.000 description 1
- 239000000051 antiandrogen Substances 0.000 description 1
- 229940030495 antiandrogen sex hormone and modulator of the genital system Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- XJFGDLJQUJQUEI-UHFFFAOYSA-N dodecyl decanoate dodecyl octanoate Chemical compound CCCCCCCCCCCCOC(=O)CCCCCCC.CCCCCCCCCCCCOC(=O)CCCCCCCCC XJFGDLJQUJQUEI-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 229940100524 ethylhexylglycerin Drugs 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- YOBAEOGBNPPUQV-UHFFFAOYSA-N iron;trihydrate Chemical compound O.O.O.[Fe].[Fe] YOBAEOGBNPPUQV-UHFFFAOYSA-N 0.000 description 1
- 229960005280 isotretinoin Drugs 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 238000002647 laser therapy Methods 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 238000002428 photodynamic therapy Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 229940055019 propionibacterium acne Drugs 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 150000003870 salicylic acids Chemical class 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 230000037384 skin absorption Effects 0.000 description 1
- 231100000274 skin absorption Toxicity 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/88—Polyamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Cosmetics (AREA)
Abstract
本申请涉及祛痘产品领域,具体公开了一种净痘乳液及其制备方法。净痘乳液由以下100重量份的原料制成:二辛基醚2‑8份,椰油醇‑辛酸酯/癸酸酯2‑8份,牛油果树果脂2‑8份,甘油1‑5份,山嵛醇0.1‑4份,甘油山嵛酸酯0.1‑3份,卵磷脂0‑2份,维生素E 0‑1份,向日葵籽油0‑1份,鲸蜡醇0.1‑2份,黄原胶0.1‑2份,聚赖氨酸0‑1份,柠檬巴毫叶提取物0‑2份,苯氧乙醇0‑1份,乙基己基甘油0‑1份,余量为去离子水。本申请的净痘乳液具有较好的祛痘效果,同时还具有较高的温和性,刺激性低,长期使用后不易产生过敏现象。
Description
技术领域
本申请涉及祛痘化妆品领域,更具体地说,它涉及一种净痘乳液及其制备方法。
背景技术
痤疮,又称为青春痘,其产生原因,一方面是雄激素分泌异常引起的皮脂腺功能亢进,一方面是毛囊异常角质化,还有一方面是细菌如痤疮丙酸杆菌、金黄色葡萄球菌的异常增生。针对痤疮的治疗,目前的做法是涂抹抗雄激素类、壬二酸类药物或者口服异维生A酸,也可以通过光动力疗法和激光疗法进行治疗,其中,最普遍的、最容易接受的还是通过使用具有祛痘效果的化妆品进行改善。
目前,市场的祛痘化妆品多以水杨酸类为主,水杨酸作为脂溶性的有机酸,可以去除皮肤角质、分解皮肤表面的皮脂,从而进行控制皮肤油脂。但长期使用容易出现角质层变薄,进而容易引起皮肤红斑、刺痛、瘙痒等过敏现象,对于皮肤敏感或皮肤角质层较薄的使用者效果不佳,会带来一定程度的负面作用。
发明内容
为了提高祛痘产品的温和性和适用性,本申请提供一种净痘乳液及其制备方法。
第一方面,本申请提供一种净痘乳液,采用如下的技术方案:
一种净痘乳液,由以下100重量份的原料制成:二辛基醚2-8份,椰油醇-辛酸酯/癸酸酯2-8份,牛油果树果脂2-8份,甘油1-5份,山嵛醇0.1-4份,甘油山嵛酸酯0.1-3份,卵磷脂0-2份,维生素E 0-1份,向日葵籽油0-1份,鲸蜡醇0.1-2份,黄原胶0.1-2份,聚赖氨酸0-1份,柠檬巴毫叶提取物0-2份,苯氧乙醇0-1份,乙基己基甘油0-1份,余量为去离子水。
通过采用上述技术方案,二辛基醚能够滋润皮肤,提高皮肤的柔软性与光滑感;椰油醇-辛酸酯/癸酸酯作为柔润剂,可以减少皮肤的水分蒸发,使皮肤柔软、有弹性;牛油果树果脂含有丰富的甘油酸和蛋白质,具有抗衰老、除皱和美白保湿作用;甘油具有补水、保湿、锁水作用,可调节皮肤的油脂分泌;山嵛醇可以滋润皮肤,使皮肤顺滑,同时还可以起到乳化和增稠作用;甘油山嵛酸酯能够使皮肤保持水润;卵磷脂具有优良的亲水性和亲油性,可以增加皮肤的光泽度,具有保湿、抗氧化作用;维生素E具有锁水、保湿、除皱作用,同时还能够促进皮肤吸收乳液;向日葵籽油具有抗炎作用,能够促进皮肤创伤愈合;鲸蜡醇既具有乳化作用,能够使乳液易于涂抹,同时还有助于乳液渗透到皮肤中,帮助皮肤吸收乳液;黄原胶具有保湿作用,能够润滑皮肤,同时还可以抗老化、除皱;聚赖氨酸具有一定的杀菌能力和热稳定性,能够抑制细菌的增生,可有效抑制痤疮的进一步产生,同时还具有保湿作用;柠檬巴毫叶提取物能够平衡皮肤油脂分泌,降低因油脂分泌过多而引起痤疮进一步产生的可能性,同时还可以促进皮肤细胞再生,增加皮肤弹性;苯氧乙醇具有一定的抗菌和防腐效果,有助于乳液的稳定保存;乙基己基甘油具有一定保湿作用,能够使皮肤保持水润,同时具有一定的防腐效果,能够增加乳液的储存稳定性。通过以上各组分的协同配合,使得祛痘乳液具有较优的祛痘效果,同时温和性高,刺激性低,长期使用后不易引起皮肤红斑、刺痛、瘙痒等过敏现象。
在一个具体的可实施方案中,由以下100重量份的原料制成:二辛基醚6-8份,椰油醇-辛酸酯/癸酸酯6-8份,牛油果树果脂5-6份,甘油3-4份,山嵛醇1-2份,甘油山嵛酸酯1-2份,卵磷脂0.5-1份,维生素E 0.2-0.3份,向日葵籽油0.3-0.5份,鲸蜡醇0.1-0.5份,黄原胶0.1-0.5份,聚赖氨酸0.1-0.5份,柠檬巴毫叶提取物0.8-1份,苯氧乙醇0.5-0.7份,乙基己基甘油0.3-0.5份,余量为去离子水。
在一个具体的可实施方案中,由以下100重量份的原料制成:二辛基醚6份,椰油醇-辛酸酯/癸酸酯6份,牛油果树果脂5份,甘油3份,山嵛醇2份,甘油山嵛酸酯1份,卵磷脂1份,维生素E 0.2份,向日葵籽油0.5份,鲸蜡醇0.1份,黄原胶0.3份,聚赖氨酸0.5份,柠檬巴毫叶提取物1份,苯氧乙醇0.51份,乙基己基甘油0.36份,余量为去离子水。
通过采用上述技术方案,通过选用特定的范围及特定的配比,使得各组分之间的协同效果达到最优,有助于乳液发挥更好的祛痘效果。
在一个具体的可实施方案中,还包括1-2重量份烟酸、1-2重量份丁香油酚和0.5-1重量份川穹提取物。
通过采用上述技术方案,烟酸在一定程度上能够扩张血管,乳液被吸收后,烟酸能够促进深层次的皮肤吸收乳液;川穹提取物在一定程度上也能够扩张血管,促进深层次的皮肤吸收乳液;丁香油酚能够促进皮肤吸收乳液,使得乳液能够渗透皮肤表层,三者有效结合,使得皮肤能够有效吸收乳液,使乳液发挥更好的祛痘效果。
在一个具体的可实施方案中,所述川穹提取物由以下方法进行制备:
取川穹,用95%乙醇回流提取3-4次,每次80-100min,合并滤液,减压浓缩,得浸膏;
将浸膏溶于水,用大孔吸附树脂和30%乙醇过滤洗脱,合并洗脱液,减压除去乙醇,真空干燥,得川穹提取物。
通过采用上述技术方案,使得川穹中的有效成分能够充分被提取。
在一个具体的可实施方案中,还包括0.2-0.5重量份的木蝴蝶提取物、0.2-0.5重量份的冬凌草提取物、0.2-0.5重量份的锦灯笼提取物和0.2-0.5重量份的黄柏提取物。
通过采用上述技术方案,木蝴蝶提取物具有抗炎作用,能够改善消除皮肤炎症;冬凌草提取物具有抗炎杀菌作用,同时,具有一定的扩张血管作用,有助于皮肤吸收乳液;锦灯笼提取物具有抑菌、抗炎作用,可抑制细菌增生,同时能够减缓皮肤炎症,有助于改善治疗痤疮;黄柏提取物具有解毒疗疮、抗炎作用,能够抗病原微生物;通过以上组分的配合,能够提高乳液的抗炎杀菌效果,进一步改善消除皮肤炎症,提高乳液对痤疮的治疗效果。
第二方面,本申请提供一种净痘乳液的制备方法,采用如下的技术方案:
一种净痘乳液的制备方法,包括以下步骤:
S1、按配比,将二辛基醚、椰油醇-辛酸酯或椰油醇-辛酸酯、牛油果树果脂、山嵛醇、甘油山嵛酸酯、卵磷脂、维生素E、向日葵籽油和鲸蜡醇,加入油相搅拌锅,加热溶解,混匀,得到油相液体物质;
S2、将去离子水加入主锅中,加热到75-80℃,边搅拌边加入已混合均匀的甘油和黄原胶的处理液,保温15-17min;
S3、将油相液体物质加入主锅中,均质;降温至45-50℃时加入聚赖氨酸、柠檬巴毫叶提取物、苯氧乙醇和乙基己基甘油,搅拌均匀;降至室温,出料,得净痘乳液。
通过采用上述技术方案,将原料组分按照油相和水相分别混合,有助于各原料组分均匀混合,使得乳液能够有效发挥治疗痤疮的功效。
在一个具体的可实施方案中, 步骤S3中,于2800rpm转速下均质10分钟,均质结束后保温15-17min。
通过采用上述技术方案,使得油相液体能够被打散成小液滴,使起乳化作用的原料能够将油相包裹成细小的乳化颗粒,有助于乳液的稳定保存和吸收。
综上所述,本申请具有以下有益效果:
1、本申请通过选用特定的原料组分进行制备祛痘乳液,温和性高,刺激性低,同时又具有较优的祛痘效果,在长期使用时不易产生皮肤红斑、刺痛、瘙痒等过敏现象。
2、本申请借助烟酸、丁香油酚和川穹提取物的配合,使得皮肤表层和深层均能够有效吸收乳液,使得乳液能够更好的发挥祛痘效果。
3、本申请借助木蝴蝶提取物、冬凌草提取物、锦灯笼提取物和黄柏提取物提高乳液的抗炎抑菌效果,改善消除皮肤的炎症,抑制细菌的增生,整体提高了乳液的祛痘效果。
具体实施方式
以下结合实施例对本申请作进一步详细说明。
本申请中木蝴蝶提取物购买自兰州沃特斯生物科技;冬凌草提取物购买自三原天域生物制品;锦灯笼提取物购买自陕西斯诺特生物技术;黄柏提取物购买自西安普瑞斯生物工程。
原料的制备例
制备例1
川穹提取物的制备,包括以下步骤:
取川穹饮片,置于8倍重量的95%乙醇中,回流提取3次,每次90min,合并滤液,通过减压浓缩,得浸膏;
将浸膏溶于2倍重量的水中,加热溶解,然后进行抽滤,收集滤液,然后将滤液过大孔吸附树脂柱,采用30%乙醇进行洗脱,收集洗脱液,减压除去乙醇,对残留物进行真空干燥,得川穹提取物。
实施例
实施例1
一种净痘乳液,每1000g由以下原料制成:二辛基醚20g,椰油醇-辛酸酯/癸酸酯20g,牛油果树果脂20g,甘油10g,山嵛醇1g,甘油山嵛酸酯1g,鲸蜡醇1g,黄原胶1g,余量为去离子水。
净痘乳液采用以下方法进行制备:
S1、称取二辛基醚、椰油醇-辛酸酯/癸酸酯、牛油果树果脂、山嵛醇、甘油山嵛酸酯和鲸蜡醇,加入油相搅拌锅中,加热至75℃,搅拌溶解,得油相液体物质;
S2、将去离子水加入到主锅中,加热至75℃,然后以20rpm的转速下加入预先混合均匀的甘油和黄原胶的处理液,保温15min;
S3、将步骤S1中的油相液体物质加入到步骤S2中的主锅中,以2800rpm转速均质10min,均质结束后保温15min,降至室温,出料,得净痘乳液。
实施例2
一种净痘乳液,每1000g由以下原料制成:二辛基醚50g,椰油醇-辛酸酯/癸酸酯50g,牛油果树果脂50g,甘油30g,山嵛醇20g,甘油山嵛酸酯20g,鲸蜡醇10g,黄原胶10g,余量为去离子水。
净痘乳液采用以下方法进行制备:
S1、称取二辛基醚、椰油醇-辛酸酯/癸酸酯、牛油果树果脂、山嵛醇、甘油山嵛酸酯和鲸蜡醇,加入油相搅拌锅中,加热至80℃,搅拌溶解,得油相液体物质;
S2、将去离子水加入到主锅中,加热至80℃,然后以30rpm的转速下加入预先混合均匀的甘油和黄原胶的处理液,保温17min;
S3、将步骤S1中的油相液体物质加入到步骤S2中的主锅中,以2800rpm转速均质10min,均质结束后保温15min,降温,出料,得净痘乳液。
实施例3
一种净痘乳液,每1000g由以下原料制成:二辛基醚80g,椰油醇-辛酸酯/癸酸酯80g,牛油果树果脂80g,甘油50g,山嵛醇40g,甘油山嵛酸酯30g,鲸蜡醇20g,黄原胶20g,余量为去离子水。
本实施例中净痘乳液的制备方法同实施例1。
实施例4
一种净痘乳液,每1000g由以下原料制成:二辛基醚20g,椰油醇-辛酸酯/癸酸酯20g,牛油果树果脂20g,甘油10g,山嵛醇1g,甘油山嵛酸酯1g,鲸蜡醇1g,黄原胶1g,卵磷脂2g,维生素E 10g,向日葵籽油2g,聚赖氨酸1g,柠檬巴毫叶提取物5g,苯氧乙醇5g,乙基己基甘油3g,余量为去离子水。
净痘乳液采用以下方法进行制备:
S1、称取二辛基醚、椰油醇-辛酸酯/癸酸酯、牛油果树果脂、山嵛醇、甘油山嵛酸酯、卵磷脂、维生素E、向日葵籽油和鲸蜡醇,加入油相搅拌锅中,加热至75℃,搅拌溶解,得油相液体物质;
S2、将去离子水加入到主锅中,加热至75℃,然后以20rpm的转速下加入预先混合均匀的甘油和黄原胶的处理液,保温15min;
S3、将步骤S1中的油相液体物质加入到步骤S2中的主锅中,以2800rpm转速均质10min,均质结束后保温15min,降温至45℃,加入聚赖氨酸、柠檬巴毫叶提取物、苯氧乙醇和乙基己基甘油,搅拌均匀,降至室温,出料,得净痘乳液。
实施例5
一种净痘乳液,每1000g由以下原料制成:二辛基醚40g,椰油醇-辛酸酯/癸酸酯40g,牛油果树果脂40g,甘油20g,山嵛醇10g,甘油山嵛酸酯5g,鲸蜡醇5g,黄原胶2g,卵磷脂5g,维生素E 1g,向日葵籽油4g,聚赖氨酸3g,柠檬巴毫叶提取物8g,苯氧乙醇8g,乙基己基甘油7g,余量为去离子水。
本实施例中净痘乳液制备方法同实施例4。
实施例6
一种净痘乳液,每1000g由以下原料制成:二辛基醚60g,椰油醇-辛酸酯/癸酸酯60g,牛油果树果脂50g,甘油30g,山嵛醇20g,甘油山嵛酸酯10g,鲸蜡醇1g,黄原胶3g,卵磷脂10g,维生素E 2g,向日葵籽油5g,聚赖氨酸5g,柠檬巴毫叶提取物10g,苯氧乙醇5.1g,乙基己基甘油3.6g,余量为去离子水。
本实施例中净痘乳液制备方法同实施例4。
实施例7
一种净痘乳液,每1000g由以下原料制成:二辛基醚70g,椰油醇-辛酸酯/癸酸酯70g,牛油果树果脂60g,甘油40g,山嵛醇30g,甘油山嵛酸酯20g,鲸蜡醇10g,黄原胶10g,卵磷脂20g,维生素E 3g,向日葵籽油7g,聚赖氨酸7g,柠檬巴毫叶提取物5g,苯氧乙醇7g,乙基己基甘油5g,余量为去离子水。
本实施例中净痘乳液制备方法同实施例4。
实施例8
一种净痘乳液,每1000g由以下原料制成:二辛基醚80g,椰油醇-辛酸酯/癸酸酯80g,牛油果树果脂80g,甘油50g,山嵛醇40g,甘油山嵛酸酯30g,鲸蜡醇20g,黄原胶20g,卵磷脂20g,维生素E 7g,向日葵籽油1g,聚赖氨酸10g,柠檬巴毫叶提取物20g,苯氧乙醇10g,乙基己基甘油10g,余量为去离子水。
本实施例中净痘乳液制备方法同实施例4。
实施例9
本实施例与实施例4的区别仅在于,原料还包括10g烟酸、10g丁香油酚和5g川穹提取物。
实施例10
本实施例与实施例4的区别仅在于,原料还包括20g烟酸、20g丁香油酚和10g川穹提取物。
实施例11
本实施例与实施例9的区别仅在于,原料还包括2g木蝴蝶提取物、2g冬凌草提取物、2g锦灯笼提取物和2g黄柏提取物。
实施例12
本实施例与实施例9的区别仅在于,原料还包括5g木蝴蝶提取物、5g冬凌草提取物、5g锦灯笼提取物和5g黄柏提取物。
对比例
对比例1
本对比例与实施例1的区别仅在于,原料中不添加二辛基醚。
对比例2
本对比例与实施例1的区别仅在于,原料中不添加椰油醇-辛酸酯/癸酸酯。
对比例3
本对比例与实施例1的区别仅在于,原料中不添加牛油果树果脂。
对比例4
本对比例与实施例1的区别仅在于,原料中不添加甘油。
对比例5
本对比例与实施例1的区别仅在于,原料中不添加山嵛醇。
对比例6
本对比例与实施例1的区别仅在于,原料中不添加甘油山嵛酸酯。
对比例7
本对比例与实施例1的区别仅在于,原料中不添加鲸蜡醇。
对比例8
本对比例与实施例1的区别仅在于,原料中不添加黄原胶。
性能检测试验
试验一、针对各实施例和各对比例中的净痘乳液参照GB/T29665-2013《护肤乳液》和《化妆品安全技术规范》进行检测,检测结果均符合相关要求。
试验二、选择健康成年雄性白兔105只,随机分为21组,其中,一组为空白组,其余为试验组,对所有的白兔进行造模,具体为在白兔左、右外耳道内侧耳管开口处于2.5cm*2.5cm范围内涂抹0.3mL油酸,一天一次,连续13天,涂抹油酸的兔耳毛囊***呈丘疹状,表明痤疮模型建造成功。
将各实施例和各对比例中的祛痘乳液分别对试验组中兔耳的痤疮处进行涂抹,每次0.5mL,一天一次,空白组对应的涂抹等量的生理盐水,连续给药30天,每天记录并观察各组中兔耳的变化,并于给药第3天、第7天、第10天、第15天、第20天和第30天对各组中祛痘乳液的治疗效果进行打分,每组取平均值。
治疗效果打分标准:
5分:兔耳皮肤恢复平滑,表面斑痕全部或基本消失。
4分:兔耳皮肤恢复平整,表面仍残留有斑痕,肉眼可见斑痕。
3分:兔耳表面留有斑痕,手触摸有凹凸感。
2分:兔耳表面仍有痤疮,但无发红、发热现象。
1分:兔耳表面仍有痤疮,仍具有发红、发热现象。
表1 试验组中祛痘乳液的治疗效果
由表1可知,给药30天后,试验组中的兔耳已全部恢复平滑,痤疮已经消失,针对试验组中已恢复正常的白兔继续给药15天,观察到白兔的兔耳未出现发热、发红、起鼓包等现象,表明无过敏现象产生。
结合表1,与空白组、对比例1至对比例8相比,在给药15天时,实施例1中的兔耳表面痤疮已消失,仅留下斑痕,给药20天时,兔耳表面已恢复平整,且给药30天时,兔耳表面已恢复平滑,斑痕也已消失,表明参照本申请公开的原料组分进行制备净痘乳液,可有效改善并消除痤疮,且长期使用,不易产生刺痛、红斑、瘙痒等过敏情况,表明本申请的净痘乳液具有较高的温和性和较低的刺激性。
参照实施例1、实施例4至实施例8,实施例1中兔耳的恢复相对较慢,表明添加的卵磷脂、维生素E、向日葵籽油、聚赖氨酸、柠檬巴毫叶提取物、苯氧乙醇和乙基己基甘油能够进一步提高净痘乳液的祛痘效果,且长期使用后未发现兔耳出现过敏现象,表明净痘乳液仍具有较优的温和性和较低的刺激性。
参照实施例4、实施例9和实施例10,实施例9和实施例10中兔耳恢复的较快,分析认为,烟酸、丁香油酚和川穹提取物的加入能够促进净痘乳液渗透皮肤,有助于皮肤表层和深层吸收净痘乳液,使得净痘乳液能够更好更快的发挥祛痘效果。
参照实施例9、实施例11和实施例12,实施例11和实施例12中兔耳恢复的较快,分析认为,木蝴蝶提取物、冬凌草提取物、锦灯笼提取物和黄柏提取物的加入能够增强净痘乳液的抗炎杀菌效果,使得净痘乳液的祛痘效果增强,从而表现为兔耳能够较快的恢复。
本具体实施例仅仅是对本申请的解释,其并不是对本申请的限制,本领域技术人员在阅读完本说明书后可以根据需要对本实施例做出没有创造性贡献的修改,但只要在本申请的权利要求范围内都受到专利法的保护。
Claims (8)
1.一种净痘乳液,其特征在于,由以下100重量份的原料制成:二辛基醚2-8份,椰油醇-辛酸酯/癸酸酯2-8份,牛油果树果脂2-8份,甘油1-5份,山嵛醇0.1-4份,甘油山嵛酸酯0.1-3份,卵磷脂0-2份,维生素E 0-1份,向日葵籽油0-1份,鲸蜡醇0.1-2份,黄原胶0.1-2份,聚赖氨酸0-1份,柠檬巴毫叶提取物0-2份,苯氧乙醇0-1份,乙基己基甘油0-1份,余量为去离子水。
2.根据权利要求1所述的一种净痘乳液,其特征在于,由以下100重量份的原料制成:二辛基醚6-8份,椰油醇-辛酸酯/癸酸酯6-8份,牛油果树果脂5-6份,甘油3-4份,山嵛醇1-2份,甘油山嵛酸酯1-2份,卵磷脂0.5-1份,维生素E 0.2-0.3份,向日葵籽油0.3-0.5份,鲸蜡醇0.1-0.5份,黄原胶0.1-0.5份,聚赖氨酸0.1-0.5份,柠檬巴毫叶提取物0.8-1份,苯氧乙醇0.5-0.7份,乙基己基甘油0.3-0.5份,余量为去离子水。
3.根据权利要求2所述的一种净痘乳液,其特征在于:由以下100重量份的原料制成:二辛基醚6份,椰油醇-辛酸酯/癸酸酯6份,牛油果树果脂5份,甘油3份,山嵛醇2份,甘油山嵛酸酯1份,卵磷脂1份,维生素E 0.2份,向日葵籽油0.5份,鲸蜡醇0.1份,黄原胶0.3份,聚赖氨酸0.5份,柠檬巴毫叶提取物1份,苯氧乙醇0.51份,乙基己基甘油0.36份,余量为去离子水。
4.根据权利要求1所述的一种净痘乳液,其特征在于:还包括1-2重量份烟酸、1-2重量份丁香油酚和0.5-1重量份川穹提取物。
5.根据权利要求4所述的一种净痘乳液,其特征在于:所述川穹提取物由以下方法进行制备:
取川穹,用95%乙醇回流提取3-4次,每次80-100min,合并滤液,减压浓缩,得浸膏;
将浸膏溶于水,用大孔吸附树脂和30%乙醇过滤洗脱,合并洗脱液,减压除去乙醇,真空干燥,得川穹提取物。
6.根据权利要求1所述的一种净痘乳液,其特征在于:还包括0.2-0.5重量份的木蝴蝶提取物、0.2-0.5重量份的冬凌草提取物、0.2-0.5重量份的锦灯笼提取物和0.2-0.5重量份的黄柏提取物。
7.权利要求1所述的一种净痘乳液的制备方法,其特征在于:包括以下步骤:
S1、按配比,将二辛基醚、椰油醇-辛酸酯/癸酸酯、牛油果树果脂、山嵛醇、甘油山嵛酸酯、卵磷脂、维生素E、向日葵籽油和鲸蜡醇,加入油相搅拌锅,加热溶解,混匀,得到油相液体物质;
S2、将去离子水加入主锅中,加热到75-80℃,边搅拌边加入已混合均匀的甘油和黄原胶的处理液,保温15-17min;
S3、将油相液体物质加入主锅中,均质;降温至45-50℃时加入聚赖氨酸、柠檬巴毫叶提取物、苯氧乙醇和乙基己基甘油,搅拌均匀;降至室温,出料,得净痘乳液。
8.根据权利要求7所述的一种净痘乳液的制备方法,其特征在于:步骤S3中,于2800rpm转速下均质10分钟,均质结束后保温15-17min。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210090264.5A CN114344218B (zh) | 2022-01-25 | 2022-01-25 | 一种净痘乳液及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210090264.5A CN114344218B (zh) | 2022-01-25 | 2022-01-25 | 一种净痘乳液及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114344218A CN114344218A (zh) | 2022-04-15 |
CN114344218B true CN114344218B (zh) | 2022-12-02 |
Family
ID=81093118
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210090264.5A Active CN114344218B (zh) | 2022-01-25 | 2022-01-25 | 一种净痘乳液及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114344218B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115212123B (zh) * | 2022-07-28 | 2023-08-01 | 广州流行美时尚商业股份有限公司 | 一种抑制皮脂分泌的植物提取组合物及其制备方法和应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104173235B (zh) * | 2014-08-11 | 2016-08-31 | 上海贝泰妮生物科技有限公司 | 一种含页岩油的复合祛痘制剂及其制备方法 |
CN105168478A (zh) * | 2015-08-28 | 2015-12-23 | 无限极(中国)有限公司 | 一种护肤品及其制备方法 |
CN106176466B (zh) * | 2016-08-30 | 2019-02-22 | 思拓科(上海)生物科技股份有限公司 | 儿童面霜及其制备方法 |
CN111297747A (zh) * | 2019-12-18 | 2020-06-19 | 康柏利科技(苏州)有限公司 | 一种喷泉乳液及其制备方法 |
CN112089654A (zh) * | 2020-09-03 | 2020-12-18 | 铂臻(广州)生物科技有限公司 | 一种祛痘组合物及其应用 |
-
2022
- 2022-01-25 CN CN202210090264.5A patent/CN114344218B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN114344218A (zh) | 2022-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113018238A (zh) | 一种抑菌消炎清爽益肤的祛痘凝胶及其制备方法 | |
CN108785200B (zh) | 一种抗菌、祛痘、抗皱的银离子保湿面膜液、面膜及其制备方法 | |
CN104434740A (zh) | 一种中药祛痘凝胶剂及其制备方法 | |
CN112043661B (zh) | 一种美白芦荟胶及其制备方法 | |
CN107519100A (zh) | 一种组合物及其制备方法和应用 | |
JP2008184440A (ja) | 紫外線細胞障害改善用皮膚外用剤 | |
CN112006958A (zh) | 脱毛膏及制备方法 | |
CN114344218B (zh) | 一种净痘乳液及其制备方法 | |
CN108992389A (zh) | 一种祛痘淡斑敷料 | |
KR102220534B1 (ko) | 수딩 크림 및 이의 제조 방법 | |
CN113384482B (zh) | 一种保湿嫩肤精华露及其制备方法 | |
KR20140048700A (ko) | 검버섯 및 잔주름 개선기능을 갖는 생약숙성탕액을 이용한 천연비누 및 그 제조방법 | |
CN114028277A (zh) | 一种具有舒缓修复敏感肌肤的安肤膏 | |
CN106137839A (zh) | 一种祛痘液 | |
CN113679640A (zh) | 一种天然滋养净肤护肤祛痘洁面凝露及其制备方法 | |
CN102872240B (zh) | 放松活络复方精油 | |
CN112516198A (zh) | 中药复方蛇油及其制备方法和应用 | |
DE202006019184U1 (de) | Feuchtigkeitsspendendes Sanddorn-Hautpflegegel | |
CN107441340B (zh) | 一种消肿止痛止痒滋养皮肤的手足皴裂膏及其制备方法 | |
CN102961275B (zh) | 一种含簕菜乙醇提取物的肤用化妆品 | |
CN109010520A (zh) | 一种治疗暗疮的药膏及其制备方法 | |
CN105106080A (zh) | 一种中草药面膜及其制备方法 | |
KR20110049201A (ko) | 여드름 피부 병변 현상 개선용 세안화장료 조성물 및 그 추출방법 | |
CN105998384A (zh) | 一种祛痘液的制备方法 | |
CN109010187A (zh) | 一种用于治疗痤疮的面霜及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A acne cleaning lotion and its preparation method Granted publication date: 20221202 Pledgee: Bank of China Limited Suzhou Xiangcheng sub branch Pledgor: CAMPARI SCIENCE & TECHNOLOGY (SUZHOU) CO.,LTD. Registration number: Y2024980003767 |